Clinical Trial Update: Communicating Multiple Uncertainties Associated With the Benefits and Risks of New Cancer Drugs [NA]

View source ↗

Summary

This study discusses how multiple uncertainties about the benefits and risks of new cancer drugs should be communicated to patients and other stakeholders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: London School of Economics and Political Science | Conditions: Cancer | NA | Status: COMPLETED